Supplemental Information Supplementary Figure 1: ESI-MS analysis of the RsmN dimer
Electrospray ionisation mass spectrum (ESI-MS) showing the presence of predominantly the dimeric species (••) in solution. Protein samples for ESI-MS were prepared by vigorous desalting through successive rounds of spin concentration using Vivaspin 500 (2 mL) centrifugal concentrators with a molecular weight cut-off (MWCO) of 3,000 Da (Sartorius Stedim). Lyophilised protein was first dissolved in 250 mM NH 4 OAc and then exchanged twice into 25 mM NH 4 OAc. ESI-MS measurements on native protein samples in 25 mM NH 4 OAc were performed on a Waters SYNAPT High Definition Mass Spectrometer with a quadrupole time-of-flight mass analyser, which was calibrated using horse heart myoglobin (16, 955 Da) . Samples were infused into the electrospray source at 5 μL min-1 using a Harvard Apparatus syringe pump 22, model 55-2222, and a 100 μL Hamilton syringe. The capillary of the ESI source was held at 2.5-3 kV, with the instrument operating in positive-ion mode. A sample cone of 40 V and desolvation gas flow rate of 100 L h -1 were maintained throughout. The ESI mass spectra were recorded by scanning a mass/charge (m/z) range of 500-5,000. MassLynx (Waters) software was used to acquire and analyse data.
Supplementary Figure 2: Structural analysis of the RsmN dimer interface
(A) Portion of the electron density map for the RsmN dimer showing the fit of part of the helix that packs against the -sheet to form part of the hydrophobic core..
(B) The amphipathic helices of RsmN form an integral part of the hydrophobic core of the dimer structure largely via residues Leu27, Ile28 and Leu31 which form mutually stabilising helix-helix interactions and contacts with residues at the ends of the -sheet and adjacent loops (Leu18, Ile36, Pro55 and Val58; see A).
(C) Structure of the RsmN dimer showing the van der Waals surfaces of the helical residues Leu27, Ile28 and Leu31 in one half of the dimer which pack against equivalent residues in the other half.
(D) Overlayed structures of the RsmE and RsmN dimers showing conservation of the -sheet structure, despite the different folds, but the completely different position and orientation of the helical motifs (RsmE, blue and RsmN, yellow). . RNA (125 μM RNA, 25 mM potassium phosphate buffer pH 7, 50 mM NaCl) was titrated into a cell containing 1.424 mL protein (510 μM protein, 25 mM potassium phosphate buffer pH 7, 50 mM NaCl).
Supplementary
(B) RNA targets RsmZ-2 and UTR-2 (rahU-2) show evidence by NMR for folded hairpin structure, however, the purine-rich pqsR is unfolded. SEC data for RsmA showing strong binding interaction with RsmZ-2 and the unstructured purine-rich pqsR, but weak interaction with UTR-2 where only a small population of the bound state is visible at equilibrium under similar conditions (see experimental methods) (colour coding: red, RNA in isolation; blue, protein; black, complex formation). . RNA (125 μM RNA, 25 mM potassium phosphate buffer pH 7, 50 mM NaCl) was titrated into a cell containing 1.424 mL protei potassium phosphate buffer pH 7, 50 mM NaCl). 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Bacterial growth and maintenance
The strains and plasmids used in this study are listed in Table 1 . Both E. coli and P. aeruginosa strains were routinely grown in LB broth or LB agar plates 37°C. Where required, antibiotics were added to media at the following concentrations: tetracycline, 25 µg/ml (E. coli) or 125 µg/ml (P. aeruginosa); gentamicin, 10 µg/ml; chloramphenicol, 250 µg/ml; spectinomycin, 1,000 µg/ml (P. aeruginosa). To counterselect E. coli S17-1 donor cells in matings with P. aeruginosa, nalidixic acid was used at a concentration of 10 µg/ml. Enrichment for tetracycline-sensitive clones was performed with tetracycline (20 µg/ml) and carbenicillin (2,000 µg/ml) as bacteriostatic and bactericidal antibiotics, respectively.
P. aeruginosa DNA manipulation
To screen for genes capable of restoring swarming in a P. aeruginosa rsmA mutant, genomic DNA was prepared from P. aeruginosa as described previously (Gamper et al., 1992) , partially digested by Sau3AI and 2-4 kb fragments cloned into pME6000, The resulting plasmids were transformed into the P. aeruginosa rsmA mutant strain PAZH13 and each clone screened for restoration of swarming. To reduce the size of the 2.5-kb chromosomal fragment cloned in pPAMMB-16, the 1.7-kb PstI-(SphI) T4 DNA Pol. fragment was first subcloned in pME6000 digested with PstI and (BamHI) T4 DNA Pol. and the 1.25-kb PstINheI fragment was deleted from the resulting plasmid. The resulting plasmid, pHS2, has an insert corresponding to the 0.47-kb NheI-SphI chromosomal fragment that carries rsmN.
The rsmNR62A allele was obtained commercially (Integrated DNA Technologies, IDT) as a 0.49-kb EcoRI-SpeI fragment equivalent to the insert in pHS2 and inserted in pME6000 to generate pHS2R62A (Table 1) . Plasmid pMM33, for the in-frame deletion of rsmN, was constructed by joining in the suicide plasmid pDM4 0.54-kb upstream and downstream fragments obtained by PCR amplification of chromosomal DNA with, respectively, oligonucleotides RSMNU and RSMND (Table 1) . Suicide plasmid construction and allelic replacement in P. aeruginosa was carried out as described elsewhere (Fletcher et al., 2007) .
Protein production and RNA preparation
The pET-28b(+) expression system (Novagen) was used to express His-tagged RsmA (His 6 -Thb-RsmA) and RsmN (His 6 -Thb-RsmN proteins) within host E. coli C41(DE3) cells, where 'Thb' indicates an LVPRGS thrombin recognition sequence. His 6 -fusion proteins were purified by using HisPur Cobalt Resin (Thermo Scientific). The manufacturer's procedure using a Gravity-flow column was followed, except for the use of a different equilibration/wash buffer (50 mM K 2 HPO 4 , 500 mM NaCl, pH 7.5), an additional high salt wash step (50 mM K 2 HPO 4 , 1 M NaCl, pH 7.5) and a different elution buffer (50 mM K 2 HPO 4 , 500 mM NaCl, 1 M imidazole). Protein overexpression with incorporation of 13 C and 15 N labelling for NMR studies was performed in M9 minimal medium supplemented with ammonium chloride (1 g L -1 of 15 NH 4 Cl and glucose (2 g L -1 13 C 6 H 12 O 6 ).
His-tagged proteins were further purified by gel filtration using a HiLoad 26/600 Superdex 75 pg column (GE Healthcare). Purified proteins were desalted into 25 mM NH 4 OAc using a HiTrap Desalting column (GE Healthcare) and subsequently lyophilised. Identity and purity were verified by electrospray ionisation-mass spectrometry and SDS-PAGE.
Multimeric state was confirmed by analytical gel filtration using a Superdex 75 column (Pharmacia Biotech), which was calibrated using a Gel Filtration LMW Calibration Kit (GE Healthcare).
Short RNA oligonucleotides were purchased from Dharmacon (Thermo Scientific), deprotected according to manufacturer's instructions, lyophilised and stored at -20°C. RNA stock solutions (~1 mM) were prepared from the lyophilised stocks. RNA hairpin formation was induced by thermally unfolding the RNA molecules at 95 °C for 1 min, with subsequent cooling and re-annealing monitored by NMR.
Analytical size exclusion chromatography (SEC)
Analytical SEC was used to confirm multimeric state of the protein after purification, as well as to monitor binding between protein and RNA. A Superdex 75 HR 10/30 analytical column (GE Life Sciences) was calibrated using a Gel Filtration LMW Calibration Kit (GE Life Sciences), which contained: aprotinin (6.5 kDa), ribonuclease A (13.7 kDa), carbonic anhydrase (29 kDa), ovalbumin (43 kDa), conalbumin (75 kDa) and blue dextran 2,000 (2 MDa). Absorbance at 280 nm was monitored to determine the elution volumes of injected samples and apparent molecular weights of species eluted in subsequent analytical SEC experiments were calculated. 50 µM protein samples in 25 mM potassium phosphate buffer pH 7, 150 mM NaCl were used to assess dimer formation of the purified RsmA and RsmN proteins. 50 µM protein and 100 µM RNA samples were used in RNA-binding SEC experiments, in a buffer containing 25 mM potassium phosphate pH 7, 50 mM NaCl.
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were recorded on a VP-ITC high sensitivity titration calorimeter (MicroCal) at 298 K. RNA and protein samples were degassed at 298 K for 10 min prior to the titration experiments. RNA (125 µM RNA, 25 mM potassium phosphate buffer pH 7, 50 mM NaCl) was titrated into a cell containing 1.424 mL µM protein, 25 mM potassium phosphate buffer pH 7, 50 mM NaCl).
Titrations consisted of one preliminary injection of 2 µL, followed by 29 injections of 10 µL, with 10 min intervals between injections. A constant stirring speed of 300 rpm ensured rapid mixing during the titration. A reference power of 6 µCal sec -1 was used. Data were analysed and fitted to a single-site model using Origin software (MicroCal).
NMR spectroscopy
NMR experiments were carried out on a Bruker Avance III 800 MHz spectrometer using an inverse detection QCI CryoProbe, fitted with Z-axis gradient. All spectra were acquired using standard Bruker pulse sequences. Protein samples in 600 μL were prepared in 25 mM potassium phosphate buffer pH 7.0, 150 mM NaCl in 90% H 2 O/10% D 2 O to give
RsmA and RsmN protein sample concentrations of 100-200 μM. Protein-RNA complexes were prepared in the same buffer solutions (but reduced salt, 50 mM NaCl) by titrating 50 μM protein samples with RNA (5-100 μM). 1D 1 H NMR spectra were collected using an excitation sculpting water suppression pulse sequence over a 13 ppm spectral width (protein) and 22 ppm width (RNA). 13 C/ 15 N-labelled proteins were used to collect 2D CBCA(CO)NH triple resonance experiments were collected for assignment purposes the quality of the spectra was low and yielded only ca. 50% of the expected correlation peaks precluding a complete backbone assignment. NMR data were acquired and processed using the TopSpin software package (Bruker) and analysed with CCPNMR software.
Crystallisation and data collection
Crystals of His-tagged RsmN were grown from the PEGs screen (QIAGEN) using sitting drop vapour diffusion from equal 1l volume mixtures of protein (500 µM H 6 -RsmN, 10 mM Tris-HCl, 150 mM NaCl, pH 7.0) and reservoir solution (0.2 M NaI, 20% (v/v) PEG 3350).
The crystals were indexed in the trigonal space group P3 1 12 and data collected to 2.0 Å resolution using the ID14-1 beamline at the ESRF (κ = 0.9334 Å). Data were processed and scaled using MOSFLM with a final R merge of 0.07 (Table 2 ).
The RsmN complex with RsmZ-2 was isolated and concentrated to 50 µM. Initial crystallisation conditions were identified using the protein-complex suite (QIAGEN). These were grown by sitting drop vapour diffusion from equal 1 l volume mixtures of protein ( PEG 8000. Data were collected at DIAMOND beamline IO3 and processed to 3.2 Å resolution of using MOSFLM (Table 2) .
Structure determination and refinement
The RsmN structure was solved by molecular replacement with PHASER (CCP4 suite) using the P. aeruginosa RsmA crystal structure (PDB code 1VPZ) as the search model. 95.6% of residues lie in the most favoured region of the Ramanchandran plot, with the remainder lying in the additional allowed area ( Table 2 ).
The structure of the RsmN-RNA complex was determined using molecular replacement with PHASER (CCP4 suite) with the RsmN structure as a model identifying two molecules in the asymmetric unit. This resulted in high quality electron density for the protein with sufficient space and additional electron density present in Fo-Fc difference maps surrounding the dimer suggestive of the presence of two RNA hairpins in the asymmetric unit. Model building of the RNA was carried out using Coot and refinement was performed using REFMAC5 with NCS restraints in place. The model was refined to R factor and R free values of 0.22 and 0.32, respectively (Table 2) . Analysis of the stereochemical quality of the structure was carried out using MolProbity (Chen et al., 2010) .
